Richard DiMarchi says academia is a place well-suited to exploratory research. “Exploring is exciting because it's where one goes in search for new knowledge, for the ability to do something that has not been done before and for the ability to see that which has not been witnessed before.”
Approximately 700,000 adults in Indiana struggle with diabetes. Obesity affects about a third of adult Hoosiers. Indiana University’s Richard DiMarchi has dedicated his career to developing cutting-edge pharmaceutical treatments to treat both conditions.
While working at Eli Lilly and Company, DiMarchi discovered the first chemically optimized human insulin. But it was at IU that he enjoyed the freedom to explore the use of GLP-1 and other peptide hormones for weight management, leading to the transformation of treatment for obesity worldwide.